Katie Flanagan

Department, Institution: Marie Curie Palliative Care Research Department, UCL Division of Psychiatry
UBEL Pathway: Health and Welfare (Mental Health and Mental Health Care)
Supervisor: Dr. Nicola White, Dr. Victoria Vickerstaff, Dr. Briony Hudson
Contact details: Catherine.flanagan.21@ucl.ac.uk
About Me:

I am a PhD student in the Marie Curie Palliative Care Research Department, based in the UCL Division of Psychiatry. Prior to starting my PhD, I completed an MSc in Psychological Sciences at UCL, where I conducted research on palliative care in Parkinson’s Disease. I also worked as a Research Assistant on the PriDem project at UCL, which aims to improve support given to people living with dementia and their families.

I decided to pursue a career in palliative care following personal experiences caring for loved ones with incurable illnesses. Prior to my career change I worked for many years at international think tanks in research and communications, working across a range of topics including urbanisation, food waste and ocean sustainability.

My Research:

My research is looking at the use of virtual reality (VR) as a therapy for people with an incurable illness. The use of VR technology in healthcare is becoming more widespread due to its increasing accessibility and affordability. This is true for its use within hospices, where VR has been used to provide people with an incurable illness the opportunity to tick off ‘bucket list’ activities, visit familiar places from their childhood, and offer distraction through playing games. VR has been shown to reduce a range of physical and psychological symptoms in people with incurable illnesses, including reducing pain and anxiety. However, across this body of literature there are many limitations, including small sample sizes and inconsistency in the way people use VR.

My PhD study will address these issues by exploring how VR could best be implemented in a hospice setting. I will use a mixed methods approach, organising focus groups with hospice users and staff to explore the attitudes of staff and patients towards VR and its use within a hospice and implementing VR in a hospice setting for 6-months to explore how often VR should be used to maximise benefits for people with an incurable illness.

Impact of My Research:

The current use of VR within many clinical settings remains haphazard, with no clear guidelines for how to integrate the use of VR into regular care, opposed to one-off sessions. These limitations make it difficult to accurately assess the impact of VR and prevent clear clinical recommendations from being drawn. My PhD study will address these knowledge gaps to identify what a VR intervention within a hospice should look like, including the optimum ‘dosage’ of VR, and where the possible therapeutic benefit may lie, maximising the benefits for people with an incurable illness.